AnaSpec, Inc. Introduces SensoLyte® Factor Xa Activity Assays - Industry's First Fluorimetric Kits

Fremont CA – January 17, 2012 -- AnaSpec, EGT Group is pleased to announce the release of the industry first fluorimetric Factor Xa activity assays - The SensoLyte® 520 Factor Xa Assay Kit and the SensoLyte® Rh110 Factor Xa Assay Kit. The SensoLyte® 520 Factor Xa Assay Kit employs a FRET (5-FAM/QXL™ 520) substrate and the SensoLyte® Rh110 Factor Xa Assay Kit, a substrate labeled with the fluorophore, Rh110. Both substrates are fluorescent substrates emitting in the green range of 520 nm, with excitation at 490 nm. The longer-wavelength spectra of 5-FAM and Rhodamine 110 provide greater sensitivity and less interference from other reaction components, making these kits ultra-sensitive. The detection limit of the SensoLyte® 520 kit can reach as low as 7.8 ng/mL while the SensoLyte® Rho110 reaches as low as 0.31 ng/mL.

Key highlights for AnaSpec’s new SensoLyte® Factor Xa Assay Kits:

• Kits optimized to detect Factor Xa enzyme activity

• Fluorometric, long wavelength (Ex/Em=490/520 nm) read-out assays

• Minimal autofluorescence

• Kits provide ample reagents to perform 100 assays in a 96-well plate format

• Assays can be completed in one hour

Factor Xa (FXa) is a serine endopeptidase composed of two disulfide-linked subunits. FXa leads to blood clot formation by converting prothrombin to thrombin through the prothrombinase complex. FXa is generated from zymogen Factor X via the intrinsic and extrinsic pathways and is the rate-limiting step in the propagation of thrombin generation. In the presence of Ca2+ ions, FXa forms prothrombinase with factor Va on the phospholipid membrane of the activated platelets.1-3 FXa has emerged as an attractive target for drug discovery for thromboembolic diseases.4,5

Reference

1. Furie, B. and Furie, BC. Cell 53:505–518 (1988).

2. Davie, EW. et al. Biochemistry 30:10363–10370(1991).

3. Mann, KG. Thromb Haemost 82:165-174 (1999).

4. Camm, AJ. and Bounameaux, H. Drugs 71:1503-1526 (2011).

5. Weitz, JI. Thromb Res 127 Suppl 2:S5-S12 (2011).

For more information, please visit http://www.anaspec.com/products/promotions.asp?col=2&row=1

AnaSpec, Eurogentec Group

AnaSpec, Eurogentec Group is a leading provider of integrated proteomics and genomics solutionsTM for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

For more information visit www.anaspec.com